News

As recently as 2010, anywhere from 18% to 36% of pediatric asthma cases were driven by traffic-related air pollution.

Investigators evaluated whether volatile anesthetics would translate into better survivability in patients undergoing coronary artery bypass grafting.

A month-long study of court decisions found malpractice was absent in telemedicine cases—but that may not indicate any strengths.

Results suggest doctors may be able to delay onset of lung disease in children born with CF.

A new 5-point clinical decision guideline could make it easier for emergency department physicians to determine which patients warrant a flu test.

Sustained virologic response rates were high among HCV/HIV coinfected patients with early treatment discontinuation the only factor associated with lower SVR rate.

Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.

Overconfidence, anchoring errors, biases, and other factors have all led to misdiagnoses at points in my internal medicine career.

Endometrial ablation with the Cerene Device does not require general anesthesia and can be performed in a gynecologist’s office.

Complete Response Letter calls for root cause analysis and data from planed registration batches.

The Complete Response Letter highlights issues in the Chemistry, Manufacturing, and Controls section of the application.

A new assessment of audio-recorded conversations show that patients' beliefs, values, and preferences are not consistently represented by surrogates and care providers.

Retrospective study assesses real-world outcomes of treating patients with chronic DME with Iluvien implant.

A new study finds it is safe for patients who undergo heart stent procedures to quit taking aspirin at 3 months so long as they continue taking a P2Y12 inhibitor.

The LAMA/LABA combination therapy was shown to reduce one-year exacerbation rates while not increasing patient risk of cardiovascular events.

Mavenclad will be marketed as a short-term oral drug option for relapsing-remitting multiple sclerosis, but it also carries malignancy risks.

Originally approved in 2002, tegaserod (Zelnorm) was withdrawn in 2007 due to potential safety concerns.

Investigators found in animal models that pulmonary endothelial function was influenced by caloric intake rates.

The study will focus on a dozen-plus children with severe asthma over a period of 4 weeks.

As Americans population ages, yet becomes more health conscious, has the average patient suffering from Afib changed in recent years?

How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?

How has technology changed the way orthopedic specialists practice and what is driving advances such as minimally invasive spine surgery?

What are some of the future risks, in terms of cardiovascular health, facing the average patient?

Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.

About 1000 people in the United States have RPE65 gene mutations and inherited retinal diseases.

Before the new treatment-resistant depression therapy reaches the market, Iosifescu anticipates its benefits and limitations in real-world patients.

The oral tablet generics approvals also come with 2 approved shared system REMS programs for ambrisentan.

Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.